- Innovations
- About Us
- …
- Innovations
- About Us
- Innovations
- About Us
- …
- Innovations
- About Us
Meet the iBreastExam
Early Detection, Like Never Before
What is the iBreastExam?
The iBreastExam is an FDA cleared hand-held, ultra-portable wireless device, usable by lay health-workers to identify and document small, non-palpable lumps, quickly and easily, at the point-of-care.
Clinically validated through independent studies involving over 25,000 women, iBreastExam is a novel technology that promises to democratize women’s health.
It's EVERYONE'S problem
2.3 Million
685,000
Deaths
Diagnosed with breast cancer in 2022
The Necessity of Early Detection
When it comes to breast cancer, early detection can be the difference between life and death. It is crucial to remember that when detected in the early stages, breast cancer is extremely treatable and there is a greater chance of full recovery.
Early detection with iBreastExam
The iBreastExam does not require an electrical outlet or a specialist to conduct a scan. terms of portability, affordability, and speed of testing and reporting, it's ahead of the game- which means that early detection of breast cancer is more accessible to all women, especially those who do not have access to traditional screening methods.
More than 2 Million women screened worldwide
iBreastExam is helping every woman in the world take their health in their own hands with an accurate, painless, radiation-free test that takes less than 10 minutes to perform.
Uses last generation imaging technology
iBreastExam Dynamic Co-Planar Capacitive Sensors accurately assess & identify tissue elasticity differences between hard & stiff breast tumors versus normal breast tissue in real-time.
The patented tactile sensor technology is a novel, quantitative and low-cost elastic modulus sensor that can measure tissue compression and stiffness by top down touching of the skin surface. iBreastExam’s ability to apply a gentle force and measure the subtle displacements electrically, all within the sensor, makes for an ideal ‘electronic palpation’ sensor for in-vivo breast examination.
A Device that saves lives
iBreastExam helps make early detection of breast cancer more accessible to all women, especially those who do not have access to traditional screening methods.
Myths and Realities
These are some of the most common beliefs of women - find out the truth about them here!
Learn more about the iBreastExam HERE
More than 2 Million Scans Done Worldwide. Clinically Validated by 25,000 Women.
Latin America has the highest rate of breast cancer rate
In 2020 there were more than
210,000
breast cancer diagnoses
More than
68,000
deaths
Awards and Recognitions
Exclusive Stories
Recognized as IHT by
Developed by
Market authorized by
UE LifeSciences Inc. Copyright © 2024 | Terms & Conditions | Privacy Policy